Armistice Capital, LLC Geo Vax Labs, Inc. Transaction History

Armistice Capital, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	BUY	$0.3 - $0.57 $487,954 - $927,114	1,626,516 New	1,626,516 $585,000
Q2 2022 Aug 15, 2022	BUY	$9.29 - $34.8 $8.58 Million - $32.1 Million	923,289 Added 212.18%	1,358,439 $1.13 Million
Q1 2022 May 16, 2022	BUY	$17.25 - $58.95 $7.51 Million - $25.7 Million	435,150 New	435,150 $500,000
Q4 2020 Feb 16, 2021	SELL	$39.45 - $85.95 $1.99 Million - $4.34 Million	-50,464 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$42.0 - $414.75 $2.12 Million - $20.9 Million	50,464 New	50,464 $161,000

Ticker GOVX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,744,000
Market Cap $55.9M
Description
GeoVax Labs, Inc., a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and cancers using modified vaccinia ankara virus-like particle vaccine platform. It is developing various preventive vaccines against (COVID-19), human immunodeficiency virus (HIV); Zika virus; malaria; and hemorrhag...

Get notified when there are updates to the investment portfolio of Armistice Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Armistice Capital, LLC with notifications on news.